抗生素与蔓越在治疗无并发性尿路感染:一个随机对照试验
Oya Güven1, Samet Sayılan2, Özlem Tataroğlu3
1Kırklareli University Medical School, Kırklareli Training and Research Hospital, Department of Emergency - Kırklareli, Turkey.
概括
蔓越提取物显著改善了与斯福米辛相比,无并发性尿路感染的患者的健康状况,并减少了症状. 这表明,蔓越是一种可行的替代方案,用于管理简单的尿路感染.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 自然产品治疗药物 自然产品治疗药物
- 传染性疾病 传染性疾病
背景情况:
- 尿路感染 (UTI) 是常见的,特别是简单或不复杂的病例.
- 抗生素耐药性需要探索尿路感染的替代治疗方法.
研究的目的:
- 评估蔓越提取物在单个尿路感染症状管理中的有效性.
- 为了比较蔓越提取物与标准抗生素治疗的有效性.
主要方法:
- 一项涉及简单尿路感染的患者的比较研究,分为两组.
- 一组接受了菌素,而另一组接受了蔓越片.
- 症状严重程度和患者的健康状况在1,3和7天使用利克尔特度量表进行了评估.
主要成果:
- 使用蔓越提取物的患者在第3天和第7天报告了明显更高的幸福感,相比于斯福米辛组.
- 治疗后的白细胞水平在蔓越和福米辛组之间是可比的.
- 在蔓越组中,从第3天开始观察到症状的改善.
结论:
- 蔓越提取物对患者的福祉和简单尿路感染的症状减少产生了有利影响.
- 蔓越为无并发性尿路感染提供了一种有希望的抗生素替代品.
- 进一步的研究可能会支持蔓越作为尿路感染的主要或辅助疗法.
更多相关视频
07:34Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis
Published on: April 16, 2019
8.2K
08:53Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
6.1K
相关概念视频
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Antibiotic Selection
53.9K
Overview
53.9K
Tonsillitis II: Management
114
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
114
Drug Elimination by Renal Route: Tubular Secretion
2.4K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K
